Physicians' Academy for Cardiovascular Education

CV Risk Master Class - Middle East

May 24-25, Dubai UAE

10' education - May 30, 2013

 

Educational Alliance to Optimize CV risk management

CV Risk Master Classes: Applying new insights to clinical practice


The lectures are recorded during the CardioVascular Risk Master Class, Middle East, Eastern Europe & African chapter, held on May 24-25, 2013 in Dubai, UAE. The presentations are intended for educational support of participants to the meeting. To view and open the presentations an additional log-on with a passcode is required. This passcode is provided to meeting participants only.

 

Click here to view the presentations

 


The challenge for CV Risk management in Middle East, Africa & Eastern Europe:
Opportunities for early intervention

Prof. John Deanfield, MD, UCL, London, United Kingdom



 

Latest insights from clinical trials:

The unassailable case for LDL-c lowering & statin therapy

Kees Hovingh, MD, Academic Medical Centre, Amsterdam, The Netherlands



 

How does BP lowering prevent the clinical manifestations of CV disease?

Prof. Richard Hobbs, MDUniversity of Oxford, United Kingdom



 

Macrovascular disease in diabetes: Opportunities for lipid management

Prof. John Betteridge, MD, UCL, London, United Kingdom



 

Novel therapies for the prevention of atherosclerotic vascular disease

Prof. John Kastelein, MD, Academic Medical Centre, Amsterdam, The Netherlands



 

The kidney & statin therapy: Friend or Foe?

Kees Hovingh, MD, Academic Medical Centre, Amsterdam,The Netherlands



 

Update on new CV Risk guidelines: an international perspective

Prof. John Deanfield, MD, UCL, London, United Kingdom


 

Start video

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.